Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee

NCT04683627 is registered in ClinicalTrials.gov with Noven Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04683627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04683627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee
Lead sponsor
Noven Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 29, 2020
Completion date
July 25, 2022
Enrollment
370 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis pain of the knee